Not inevitably. Chronic migraine moves in both directions, and a meaningful proportion of people return to an episodic pattern. What tends to drive more headache days is largely identifiable: acute medication taken too often, disrupted sleep, untreated sleep apnoea and unmanaged mood.
Not inevitably. Chronic migraine moves in both directions, and a meaningful proportion of people return to an episodic pattern. What tends to drive more headache days is largely identifiable: acute medication taken too often, disrupted sleep, untreated sleep apnoea and unmanaged mood.
Chronic migraine describes headache on fifteen or more days a month for more than three months, with migraine features on at least eight of them. It is a description of the current pattern, not a permanent category. Movement between episodic and chronic in both directions is well documented, and reversion to an episodic pattern is a realistic treatment goal rather than an optimistic one. Framing it as a fixed diagnosis tends to discourage exactly the changes that most often shift it.
Medication overuse is the commonest modifiable driver. Acute treatments taken on too many days each month sustain the very pattern they are being used against, and the threshold differs by drug class rather than being a single number of tablets. Poor or irregular sleep, untreated obstructive sleep apnoea, depression and anxiety, high caffeine intake, and skipped meals all contribute. Neck pain and jaw clenching feed in for some people. None of these are moral failings; they are levers.
Preventive treatment aims to reduce the number of headache days and the severity of the ones that occur, not to abolish migraine. Several classes are used, chosen against the person's other conditions and preferences rather than by ranking. Botulinum toxin injection is established specifically for chronic migraine and is provided at this practice. Treatments targeting the CGRP pathway are an option for suitable patients. Any preventive needs a fair trial at an adequate level before it is judged, which is the step most often cut short.
By counting, not by impression. A simple diary of headache days, days on which acute medication was taken, and days when work or family life was disrupted gives a far more reliable picture than recall at a review appointment, and it shows a downward trend before it feels like one. That record also identifies whether acute medication use is sitting above the level that sustains the problem. Review then has something to work with, for adults 18 and older at either office.
Clinical Neurology Specialists has been physician-owned since 1998, when Leo Germin, M.D., FAANEM founded it. Five board-certified neurologists and four advanced practice providers see patients at the Las Vegas and Henderson offices, each with its own AANEM-accredited electrodiagnostic laboratory.
Clinical Neurology Specialists is an adult outpatient neurology practice for patients 18 and older. The practice performs no surgery and operates no imaging suite, infusion suite or interventional pain programme, and provides no emergency or inpatient care.
Physician-reviewed. Reviewed by the physicians of Clinical Neurology Specialists — board-certified neurologists, AANEM-accredited electrodiagnostic laboratories, physician-owned since 1998. Reviewed 1 August 2026. This article is general education for adults 18 and older and is not a substitute for a consultation.
Sources and further reading: MedlinePlus: migraine; MedlinePlus: headache; American Academy of Neurology.
Adults 18 and older, at the Las Vegas and Henderson offices. Call 702-804-1212 or request an appointment online.